Andrea created a best-in-class “beyond the pill” experience for patients suffering with major depressive disorder (MDD) through an omni-channel approach, leveraging digital and artificial intelligence capabilities to improve patient outcomes and address the immediate need of patient adherence. As a result, over 215,000 patients are currently enrolled in the program today.

In April 2018, she was recognized as a top 5% performer across Takeda’s Marketing General Medicine Business Unit for demonstrating global core competencies that deliver business-impactful programs

Andrea validates investment levels and presents new optimizations to drive smarter investments for the business (over $11MM in savings and generating millions in revenue).